| | | | |
| | RegenMD | | |
| | | | |
| | | | |
| | | based regenerative medicine company Advanced BioHealing Inc., has filed for a $200 million initial public offering. Bank of American, Merrill Lynch and JP Morgan are serving as co-lead underwriters, with participation by Wells Fargo Securities, ... See all stories on this topic » | Citybizlist (press release) | | | | | | |
| |
| | | | |
| | | | |
| | | "We look forward to conducting studies to determine the safety and efficacy of the novel cellular therapies developed by CellSeed and to expanding the possibilities of regenerative medicine." CellSeed has developed a method for taking small quantities ... See all stories on this topic » | | | | | |
| |
| | | | |
| | | | |
| | | The new building, located on the University of California, San Francisco campus, was completed by Rafael Viñoly Architects earlier this month, and is now occupied by the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, ... See all stories on this topic » | Co.Design | | | | | | |
| |
| | | | |
| | | | |
| | | Cytori Therapeutics, a developer of medical products and devices to enable the practice of regenerative medicine, has received a patent from the Japan Patent Office for its Celution system. The patent covers devices for extracting and concentrating the ... See all stories on this topic » | | | | | |
| |
| | | | |
| | | | |
| | | ... heard two presentations from leading researchers at the school: one on cancer research and the other on stem cells and tissue engineering, he added. ... | | | | | |
| |
| | | | |
| | | | |
| | | They are in the process of acquiring patents for the technology, which could be used in other areas of biomedical research, such as tissue engineering, ...
| The Engineer | | | | | | |
| |
| | | | |
| | | | |
| | | The list includes the $47.2 million purchase of Japan Tissue Engineering Co. in August. Fujifilm, which makes equipment for medical scans, ... | | | | | |
| |
| | | | |
| | | | |
| | | With the advancement in genetic engineering, microbiology and synthetic ... or bone cells in a process researchers call "programmed tissue engineering. ... | | | | | |
| |
| | | | |
| | | | |
| | | These induced pluripotent stem (iPS) cells can develop into most other cell types and are a source of great hope for use in regenerative medicine and the development of new drugs to prevent and treat various illnesses. One aspect of regenerative ... See all stories on this topic » | | | | | |
| |
| | | | |
No comments:
Post a Comment